- All
- Brand Insights
- Brand Insights Blog Series
An Analysis of the Brand Names for Novel Drugs Approved by FDA CDER in 2024
In 2024, there were 50 novel drugs approved by the FDA’s Center for Drug Evaluation and Research (CDER). Of those […]
Part 1: Unique and Unmistakable: Canada’s LASA Testing for Safer Drug Names
Medication errors with medicine giving are among the most avoidable dangers in health care, but they still threaten patient safety […]
Clearing a Global Pharmaceutical Trademark
Pharmaceutical companies generally plan to sell their pharmaceutical products in more than one country. Ideally, they will seek a product […]
Hurdles to Overcome When Developing a Brand Name
What makes a great brand name? That depends on who you ask. One thing is for certain, whether developing a […]
Preserving Patient Safety: Understanding the Risks of Look-Alike and Sound-Alike Drug Names
Patient safety is a critical aspect of the Healthcare Industry that involves protecting patients from harm and ensuring that they […]
The Value of Consumer Brand Name Market Research
When it comes to consumer products, choosing the right name can be a critical factor in determining a brand’s success. […]
The Crucial Role of Linguistic Appropriateness in Branding
The challenges of developing a new brand or nonproprietary name are relatively well known. Whether it be a pharmaceutical product, […]
The Importance of a Drug Name from a European Perspective
When it comes to marketing a new drug in Europe, choosing the right name can be critical to the success […]
Developing a Pharmaceutical Brand Name for the Japanese Market? Here’s What You Need to Know
Developing a new pharmaceutical brand name can be a complex process, particularly in Japan where there are unique guidelines and […]
The Canadian Regulatory Landscape for Pharmaceutical Brand Naming
Pharmaceutical brand naming is a crucial aspect of the Canadian healthcare industry as it helps to create a unique identity […]
The Importance of Timing in Pharmaceutical Brand Naming
Bringing a drug to market in the healthcare world is a marathon and a sprint. One integral part of that […]
The Importance of a Well-Designed Corporate Logo
The corporate logo is one of the most essential elements of a company’s visual identity. It’s a symbol that represents […]
ANVISA: The Most Mature Pharmaceutical Regulatory System in Latin America
The Brazilian regulatory Agency, Anvisa (Agência Nacional de Vigilância Sanitária) issues market authorizations for medical devices and pharmaceuticals; exercises post-marketing […]
In 2023, One Brand Name Development Strategy is Rising to the Forefront
As of today, 13 novel drug names have been approved by the FDA in 2023. And of those 13 names […]
Branded Generics: Differentiating Your Generic Drug Product with a Strong Brand Name
Branded generic drug products are generic drugs that are marketed under a brand name. Examples of branded generics include Claravis […]
From Letters to Language: The Evolution of Clinical Trial Naming Conventions
Clinical trials are an essential part of the drug development process. They are a crucial tool for evaluating the safety […]
Why Guess When You Can Test? The Importance of Market Research in Pharmaceutical Brand Naming
In the highly competitive pharmaceutical industry, creating a brand name that stands out is crucial to gaining market share and […]
Two Brands, One Drug: The Potential Benefits and Challenges of Dual Branding
Dual branding in the pharmaceutical industry refers to a marketing strategy where a single product is marketed under two different […]
Building a Reputation of Excellence: Brand Institute’s Journey
Welcome to Brand Institute, where we deliver the highest quality branding-and-naming-related products and services to our invaluable customers, and where […]
The Power of Trademark Analytic Data in Crafting Effective Brand Names
The process of creating a strong brand identity is crucial to the success of every product. An essential component of […]
Biosimilar Naming: Balancing Competition and Compliance
Biosimilars have been gaining a lot of attention in recent years as an alternative to expensive biologic drugs. Biosimilars are […]
Brand Name Approvals for Medicinal Products in the European Union: A Vital Part of Drug Safety
Distinctive brand names are essential in the pharmaceutical industry, as they play a crucial role in mitigating name-related medication errors. […]
The Rise of the Letter Y in Pharmaceutical Brand Naming
The use of the letter y in pharmaceutical brand names has been steadily increasing over the last two decades. In the five-year […]
A Suffix Like No Other – Navigating the Nonproprietary Naming of Biological Products
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
Naming Strategies in Pharmaceutical Brand Name Development
One of the questions I am often asked about pharmaceutical brand naming is, “Where do you start?” The public, and […]
Standing Out in the Nonproprietary Naming Arena
When it comes to developing nonproprietary names for pharmaceuticals and biologics, the goal remains consistent: to obtain an appropriate name […]